๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Expression of epidermal growth factor receptor (EGFr) immunoreactivity in human cutaneous nerves and sensory corpuscles

โœ Scribed by Vega, J. A. ;Vazquez, E. ;Naves, F. J. ;Calzada, B. ;Del Valle, M. E. ;Represa, J. J.


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
998 KB
Volume
240
Category
Article
ISSN
0003-276X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Differential expression of epidermal gro
โœ Li Dao Ke; Karen Adler-Storthz; Gary L. Clayman; Alfred W. K. Yung; Zhuo Chen ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 165 KB ๐Ÿ‘ 2 views

## Background: Over-expression of human epidermal growth factor receptor (egfr) is associated with a variety of human malignancies, including head and neck cancer. it has also been studied for its effect on cancer cell responses to chemotherapy. to accurately measure changes in egfr expression that

Sensory epithelium of the vomeronasal or
โœ Garcia-Suarez, O. ;Germanร , G. ;Naves, F.J. ;Ciriaco, E. ;Represa, J. ;Vega, J.A ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 915 KB

## Background: The medial wall of the vomeronasal organ (VNO) is lined with a sensory epithelium that is closely related to the olfactory epithelium, which is developed from the olfactory placode. It undergoes continuous replacement during its life span. In other sensory epithelia, cell proliferat

Antitumor activity of the selective epid
โœ Ichiro Naruse; Tohru Ohmori; Yoko Ao; Hisao Fukumoto; Toshio Kuroki; Masatomo Mo ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 216 KB ๐Ÿ‘ 1 views

## Abstract Selective tyrosine kinase inhibitors are regarded as promising antitumor agents for cancer treatment. Iressaยฎ (ZD1839) is an orally active, selective EGFRโ€TKI (epidermal growth factor receptorโ€tyrosine kinase inhibitor) that blocks signal transduction pathways implicated in cancer cell

Inhibition of proliferation and inductio
โœ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 297 KB ๐Ÿ‘ 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant